Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 26 studies | 30% ± 11% | |
smooth muscle cell | 13 studies | 24% ± 5% | |
endothelial cell | 8 studies | 24% ± 7% | |
astrocyte | 6 studies | 28% ± 9% | |
GABAergic neuron | 4 studies | 33% ± 12% | |
glutamatergic neuron | 3 studies | 47% ± 12% | |
fibroblast | 3 studies | 26% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 9121.97 | 180 / 180 | 99% | 36.88 | 426 / 430 |
breast | 100% | 9852.44 | 459 / 459 | 98% | 25.82 | 1098 / 1118 |
kidney | 100% | 8822.04 | 89 / 89 | 97% | 40.23 | 877 / 901 |
thymus | 100% | 15040.59 | 653 / 653 | 96% | 37.45 | 579 / 605 |
brain | 93% | 8208.06 | 2455 / 2642 | 99% | 44.57 | 701 / 705 |
prostate | 100% | 10657.93 | 244 / 245 | 91% | 17.16 | 456 / 502 |
lung | 100% | 12247.83 | 577 / 578 | 89% | 17.42 | 1031 / 1155 |
uterus | 99% | 15784.44 | 169 / 170 | 80% | 16.45 | 366 / 459 |
esophagus | 86% | 10494.20 | 1242 / 1445 | 87% | 18.39 | 159 / 183 |
skin | 81% | 4074.97 | 1471 / 1809 | 91% | 19.68 | 430 / 472 |
bladder | 100% | 10517.62 | 21 / 21 | 70% | 9.85 | 353 / 504 |
stomach | 90% | 6636.31 | 322 / 359 | 74% | 13.07 | 213 / 286 |
intestine | 93% | 10441.30 | 896 / 966 | 63% | 8.99 | 333 / 527 |
adrenal gland | 67% | 2377.97 | 172 / 258 | 75% | 31.15 | 172 / 230 |
pancreas | 33% | 979.28 | 109 / 328 | 95% | 21.22 | 169 / 178 |
adipose | 100% | 11678.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 28196.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 7949.05 | 849 / 861 | 0% | 0 | 0 / 0 |
spleen | 98% | 5322.91 | 237 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 16.76 | 76 / 80 |
muscle | 63% | 2057.41 | 509 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 6.58 | 28 / 45 |
liver | 8% | 245.32 | 17 / 226 | 30% | 4.57 | 120 / 406 |
lymph node | 0% | 0 | 0 / 0 | 17% | 1.34 | 5 / 29 |
peripheral blood | 4% | 139.93 | 37 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0005829 | Cellular component | cytosol |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ARHGEF17 |
Protein name | Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4) Rho guanine nucleotide exchange factor 17 ARHGEF17 |
Synonyms | TEM4 KIAA0337 |
Description | FUNCTION: Acts as a guanine nucleotide exchange factor (GEF) for RhoA GTPases. . |
Accessions | Q96PE2 ENST00000263674.4 ENST00000643371.1 ENST00000544519.1 A0A2X0TVV1 A0A2R8Y4D7 H0YFZ8 |